Neurobo Pharmaceuticals Inc
(NRBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRBO | AZN | AMGN | GILD | BMY |
| Company | Neurobo Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.35 | 202.52 | 366.66 | 153.42 | 60.00 |
| High | 2.44 | 205.53 | 369.50 | 155.73 | 60.93 |
| Low | 2.32 | 202.10 | 365.06 | 150.82 | 59.25 |
| Latest | 2.36 | 204.94 | 367.99 | 152.68 | 60.43 |
| Change | +0.01 | +0.18 | +1.41 | -3.12 | +0.50 |
| % Change | +0.43% | +0.09% | +0.38% | -2.00% | +0.83% |
| Volume | 13,000 | 1,596,392 | 827,544 | 4,540,565 | 5,879,946 |
| 20-Day Average Volume | 35,165 | 4,555,877 | 3,142,692 | 8,641,069 | 13,301,841 |
| Previous Close | 2.35 | 204.76 | 366.58 | 155.80 | 59.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.50 | 188.71 | 351.54 | 140.37 | 56.87 |
| 20-Day Raw Stochastic | 22.27% | 95.35% | 71.79% | 85.14% | 82.25% |
| 20-Day Relative Strength | 40.86 | 64.26 | 60.85 | 67.33 | 65.82 |
| Weighted Alpha | -57.49 | +47.53 | +32.73 | +55.34 | +23.79 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 48% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.67% since 11/20/24 | +8.95% since 02/05/26 | -0.15% since 02/05/26 | +1.69% since 02/05/26 | +1.71% since 02/05/26 |
| Low | 2.30 on 11/26/24 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 2.54 on 11/25/24 | 205.18 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -15.11% since 10/25/24 | +8.90% since 01/12/26 | +12.81% since 01/12/26 | +23.89% since 01/12/26 | +8.55% since 01/12/26 |
| Low | 2.18 on 11/15/24 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.54 on 01/21/26 |
| High | 3.00 on 10/28/24 | 205.18 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -31.79% since 08/27/24 | +16.29% since 11/12/25 | +9.20% since 11/12/25 | +23.09% since 11/12/25 | +23.35% since 11/12/25 |
| Low | 2.08 on 10/10/24 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 4.32 on 09/09/24 | 205.18 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -42.86% since 05/24/24 | +35.33% since 08/12/25 | +28.86% since 08/12/25 | +26.55% since 08/12/25 | +30.05% since 08/12/25 |
| Low | 2.08 on 10/10/24 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 5.30 on 06/27/24 | 205.18 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,334 | 317,563,904 | 197,396,352 | 193,297,952 | 122,002,680 |
| Shares Outstanding, K | 8,616 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -12,470,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -5,650,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | -0.26 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/07/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/27/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 23.88 | 16.69 | 18.07 | 9.90 |